1. Home
  2. TEO vs MLYS Comparison

TEO vs MLYS Comparison

Compare TEO & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEO
  • MLYS
  • Stock Information
  • Founded
  • TEO 1979
  • MLYS 2019
  • Country
  • TEO Argentina
  • MLYS United States
  • Employees
  • TEO N/A
  • MLYS N/A
  • Industry
  • TEO Telecommunications Equipment
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TEO Telecommunications
  • MLYS Health Care
  • Exchange
  • TEO Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • TEO 3.4B
  • MLYS 3.1B
  • IPO Year
  • TEO N/A
  • MLYS 2023
  • Fundamental
  • Price
  • TEO $11.88
  • MLYS $38.08
  • Analyst Decision
  • TEO Hold
  • MLYS Strong Buy
  • Analyst Count
  • TEO 2
  • MLYS 6
  • Target Price
  • TEO $9.60
  • MLYS $44.60
  • AVG Volume (30 Days)
  • TEO 457.5K
  • MLYS 1.0M
  • Earning Date
  • TEO 11-07-2025
  • MLYS 11-10-2025
  • Dividend Yield
  • TEO 1.71%
  • MLYS N/A
  • EPS Growth
  • TEO N/A
  • MLYS N/A
  • EPS
  • TEO N/A
  • MLYS N/A
  • Revenue
  • TEO $4,338,754,502.00
  • MLYS N/A
  • Revenue This Year
  • TEO $91.61
  • MLYS N/A
  • Revenue Next Year
  • TEO $10.21
  • MLYS N/A
  • P/E Ratio
  • TEO N/A
  • MLYS N/A
  • Revenue Growth
  • TEO 11.12
  • MLYS N/A
  • 52 Week Low
  • TEO $6.43
  • MLYS $8.24
  • 52 Week High
  • TEO $15.54
  • MLYS $44.80
  • Technical
  • Relative Strength Index (RSI)
  • TEO 72.55
  • MLYS 46.20
  • Support Level
  • TEO $10.46
  • MLYS $38.00
  • Resistance Level
  • TEO $12.59
  • MLYS $43.43
  • Average True Range (ATR)
  • TEO 0.74
  • MLYS 2.09
  • MACD
  • TEO 0.32
  • MLYS -0.88
  • Stochastic Oscillator
  • TEO 88.82
  • MLYS 19.40

About TEO Telecom Argentina SA

Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company provides services in Argentina (mobile, cable television, Internet and fixed and data services), Paraguay (mobile, Internet and satellite TV services), Uruguay (cable television services), the United States (fixed wholesale services) and Chile (Cybersecurity services and products).

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: